Nanomedicine in Theranostics

Nanomedicines in Theranostics are advantageous over standard low-molecular-weight drugs in several different regards. They reduce renal excretion and/or hepatic degradation, leading to prolonged circulation times, reduce the volume of distribution, leading to less accumulation in healthy non-target tissues (‘site-avoidance drug delivery’), improve the ability of drugs to accumulate at pathological sites (‘site-specific drug delivery’) and improve the therapeutic index of drugs, by increasing their accumulation at the target site and/or reducing their localization in potentially endangered healthy organs. In addition, nanomedicine formulations assist low-molecular-weight (chemo-) therapeutic agents in overcoming several additional barriers to efficient drug delivery to pathological sites. We show that theranostic nanomedicines are highly suitable systems for monitoring drug delivery, drug release and drug efficacy. The (pre)clinically most relevant applications of theranostic nanomedicines relate to their use for validating and optimizing the properties of drug delivery systems, and to their ability to be used for pre-screening patients and enabling personalized medicine.

 

  • Theranostic Targeting Vectors
  • Molecular Therapeutics
  • System Biology and Translational Medicine
  • Future Theranostic Applications
  • Innovative Applications for Diagnosis

Related Conference of Nanomedicine in Theranostics

September 24-25, 2018

Middle East Pharmacy and Pharmaceutical Conference

Abu Dhabi, UAE
September 24-26, 2018

12th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
September 24-26, 2018

7th International Conference on Clinical Trials

| Chicago, Illinois, USA
(10 Plenary Forums - 1 Event)
September 28-29, 2018

11th World Congress on Pharmaceutical Sciences

| Montreal, Canada
October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
November 05-07, 2018

18th Annual Pharma Middle East Congress

Abu Dhabi, UAE
November 14-15, 2018

13th World Congress on Pharmacology and Toxicology

Melbourne, Australia
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Berlin, Germany
Feb 28-March 01, 2019

International Conference on Bio-Pharmaceuticals

Osaka, Japan
April 22-23, 2019

6th World Congress on Drug Discovery & Toxicology

Abu Dhabi, UAE
March 25-26, 2019

World Congress on Pharmaceutical Biotechnology & Bioengineering

Orlando, Florida, USA
March 27-28, 2019

5th International Conference on Clinical Pharmacy and
Health Care

San Antonio, Texas, USA
April 04-06, 2019

4th Annual Congress on Nanomedicine and Drug Delivery

Auckland, NewZealand
April 15-16, 2019

12th European Biosimilars Congress

Berlin, Germany
April 17-18, 2019

11th World Congress on Pharmacology & Therapeutics

Montreal, Canada
April 17-18, 2019

Annual Neurochemistry and Neuropharmacology Congress

| Montreal, Canada
April 17-18, 2019

International Conference on Global Analytica

Osaka, Japan
May 20-21, 2019

21st Annual European Pharma Congress

Zurich, Switzerland
April 22-24, 2019

20th Asia-Pacific Pharma Congress

Tokyo, Japan
March 22-23, 2019

5th International Conference on Antibiotics

Orlando, USA
June 17-18, 2019

14th World Congress on Pharmacology and Drug Safety

Lisbon, Portugal
August 19-20, 2019

24th World Congress on Pharmacology

Vienna, Austria
September 11-13, 2019

8th International Conference on Clinical Trials

| Orlando, Florida, USA

Nanomedicine in Theranostics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in